Related content

Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment

By Kilic Sevtap   Yilmaz Nafiye   Zulfikaroglu Ebru   Erdogan Gokcen   Aydin Murat   Batioglu Sertac  

Gynecological Endocrinology, Vol. 27, Iss. 9, 2011-09 ,pp. : 622-629

Informa Healthcare

Access to resources Recommend Favorite

Obesity and insulin resistance in women with polycystic ovary syndrome

By Chun-Sen Hsu   Chien-Hua Wu   Wan-Chun Chiu   Ching-Tzu Lee   Chun-Jen Chang   Ming-I Hsu  

Gynecological Endocrinology, Vol. 27, Iss. 5, 2011-05 ,pp. : 300-306

Informa Healthcare

Access to resources Recommend Favorite

Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome

By Costa Eduardo Caldas   Ferezini de Sá Joceline Cássia   Mafaldo Soares Elvira Maria   Araújo Moura Lemos Telma Maria   de Oliveira Maranhão Técia Maria   Dantas Azevedo George  

Gynecological Endocrinology, Vol. 28, Iss. 1, 2012-01 ,pp. : 12-15

Informa Healthcare

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome

By Tziomalos Konstantinos   Katsikis Ilias   Papadakis Efstathios   Kandaraki Eleni A.   Macut Djuro   Panidis Dimitrios  

Human Reproduction, Vol. 28, Iss. 3, 2013-03 ,pp. : 785-793

Oxford University Press

Access to resources Recommend Favorite